Anti-inflammatory effect of echinacoside in collagen-induced arthritis via Nrf2/Drp1 pathway
Advances in Clinical and Experimental Medicine · 2024
DOI: 10.17219/acem/184640 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical and Experimental Medicine, 2024. Verfasst von Xiaoyan Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostics, Shaanxi University of Chinese Medicine, Xianyang, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Glycosides, Arthritis, Experimental, Anti-Inflammatory Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnostics, Shaanxi University of Chinese Medicine, Xianyang, China.
- Faculty of Medical Technology, Shaanxi University of Chinese Medicine, Xianyang, China.
- College of Basic Medicine, Shaanxi University of Chinese Medicine, Xianyang, China.
- Department of Orthopedics, Tangdu Hospital, The Second Affiliated Hospital of Air Force Medical University, Xi'an, China.
Zitieren
APA
Wang, X., Li, L., Zhang, M., Ji, R., Li, N., Wang, K., & Chen, Z. (2024). Anti-inflammatory effect of echinacoside in collagen-induced arthritis via Nrf2/Drp1 pathway. Advances in Clinical and Experimental Medicine. https://doi.org/10.17219/acem/184640
Vancouver
Wang X, Li L, Zhang M, Ji R, Li N, Wang K, et al. Anti-inflammatory effect of echinacoside in collagen-induced arthritis via Nrf2/Drp1 pathway. Advances in Clinical and Experimental Medicine. 2024. doi:10.17219/acem/184640
BibTeX
@article{Wang2024,
author = {Wang, Xiaoyan and Li, Lingxinyu and Zhang, Mengyun and Ji, Ruike and Li, Na and Wang, Kun and Chen, Zhufeng},
title = {Anti-inflammatory effect of echinacoside in collagen-induced arthritis via Nrf2/Drp1 pathway},
journal = {Advances in Clinical and Experimental Medicine},
year = {2024},
doi = {10.17219/acem/184640}
}
EUVIMED